Haft Nicholas 13D/13G Filings for Finch Therapeutics Group, Inc. (FNCH)

Haft Nicholas 13D and 13G filings for Finch Therapeutics Group, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-03-29
4:41 pm
Purchase
2021-03-19 13D Finch Therapeutics Group, Inc.
FNCH
Haft Nicholas 133,102
8.500%
133,102increase
(New Position)
Filing